FindTrial
Sign In

Mind the Gap: Missing Links in Childhood Migraine Treatment

Characterizing gaps in the Pharmacologic Treatment of Childhood Migraine and its Association with Quality of Life: A Single-center Descriptive Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/083972
Enrollment
30
Registered
2025-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43- Migraine

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Sarthak Joshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 6-12 years fulfilling the International Headache Society (ICHD-3) diagnostic criterion for migraine

Exclusion criteria

Exclusion criteria: Mixed headache Unable to read or understand either Hindi/English

Design outcomes

Primary

MeasureTime frame
To document the current acute and preventive pharmacologic treatment in children newly diagnosed with migraine.Timepoint: At baseline.—

Secondary

MeasureTime frame
To compare these treatment practices with the standard treatment guidelines, to identify the gaps in treatment.Timepoint: At baseline;To analyze the association between the gaps in pharmacological treatment with the quality of life of children with migraine.Timepoint: At baseline—

Countries

India

Contacts

Public ContactSarthak Joshi

Maulana Azad Medical College

drdmishra@gmail.com9968604316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026